Skip to main content
Clinical Trials/ISRCTN74802813
ISRCTN74802813
Completed
未知

A randomised feasibility trial to determine the impact of timing of surgery and chemotherapy in newly diagnosed patients with advanced epithelial ovarian, primary peritoneal, or fallopian tube carcinoma

Medical Research Council (UK)0 sites550 target enrollmentJanuary 25, 2006

Overview

Phase
未知
Intervention
Not specified
Conditions
Advanced epithelial ovarian, primary peritoneal or fallopian tube carcinoma
Sponsor
Medical Research Council (UK)
Enrollment
550
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

2015 Results article in http://www.ncbi.nlm.nih.gov/pubmed/26002111 results

Registry
who.int
Start Date
January 25, 2006
End Date
August 30, 2010
Last Updated
3 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Medical Research Council (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. Clinical and imaging evidence of a pelvic mass with extrapelvic metastatic disease at presentation
  • 2\. Randomisation should be carried out within 4 weeks of obtaining clinical and imaging evidence of disease
  • 3\. Serum Cancer Antigen (CA 125\) / CarcinoEmbryonic Antigen (CEA) ratio \>25 (if the serum CA 125/CEA is less than or equal to 25 and the serum CEA is above the upper limit of normal, the patient should undergo investigations to exclude gastrointestinal cancer)
  • 4\. Patient planned to receive carboplatin\-based chemotherapy
  • 5\. Patient fit to undergo protocol treatment and follow\-up
  • 6\. No concomitant or previous malignancy likely to interfere with protocol treatments or comparisons
  • 7\. Written informed consent of the patient

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials